Hinge Health is trading 4.3% down at $76.03 following a post-earnings reversal, despite reporting strong Q2 results and raising its full-year guidance.
- The company reported 53% revenue growth to $212.8 million and beat EPS estimates, while announcing a $105 million acquisition of Cylinder Health to expand into GI care.
- The downward move appears to be a technical reversal rather than a market-wide selloff, as broader U.S. pre-market indices are trading modestly higher.